Canopy Growth Corp (TSX:WEED) at $55: Should Investors Buy the Dip?

Why now might be an opportune time for investors to buy Canopy Growth Corp (TSX:WEED)(NYSE:CGC).

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has been falling recently, well below the $60 mark and the last time it closed below $56 was back in January. The big question for investors is whether this is the start of a bigger correction taking place, or if it’s likely that we’ll see the stock rebound from where it is today.

The challenge with many marijuana stocks, however, is that they all trade at significant multiples and trying to gauge where their price should be is difficult at best. With Canopy Growth struggling to post a consistent profit and trading at a price-to-sales ratio of over 100, it’s easy to say that it’s an expensive buy and end the discussion right there. The problem is that marijuana stocks have not followed that pattern and it almost puts them into a unique category.

Given the impressive growth we’ve seen from some marijuana stocks lately, it’s not something that’s comparable to even a big growth stock like Amazon, which will only see its sales rise at a fraction of what Canopy Growth and its peers are able to grow at. And so using conventional approaches to very unconventional stocks, especially as the industry has just launched, makes it almost pointless to do so. Investors have to almost look at marijuana stocks the way they might IPOs, where there’s a lot of opportunity and risk.

In Canopy Growth’s case, the company is definitively the market leader. It’s a name that has become synonymous with the industry and the brand has a lot of value today. While I won’t say that Canopy Growth is a cheap buy, because it’s hard to justify that given it has a market cap of around $20 billion, I will say that I don’t expect that we’ll see a big correction happen just yet. And this latest decline isn’t specific to Canopy Growth itself, but the markets as a whole, as many stocks have been down recently.

Canopy Growth’s share price is also approaching oversold territory as it has a Relative Strength Index (RSI) below 40. If it hits 30, that’s a sign that the selling we’ve seen has been excessive and that it might be due for a reversal. However, if you’re waiting for it to get to that level, you might be holding your breath for a long time, as that’s a very rare occurrence for the stock.

The last time that it was below an RSI of 40 was back at the end of last year, when the stock was trading below $40 a share. Since then, the stock has obviously climbed to much greater heights. That said, I don’t see Canopy Growth rising another +50% the way it did during that time, but I wouldn’t be surprised if it found its way back up to over $60.

For those reasons, I wouldn’t be surprised to see the stock start to rally sometime soon.

Bottom line

With the markets not being particularly strong right now, I believe what’s happening to Canopy Growth’s stock is more related to the market rather than the individual stock itself, and that’s why I wouldn’t be surprised it rebound. There’s still a lot of growth happening in the cannabis industry and a lot of excitement for us to be expecting a big correction to be taking place just yet.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of Amazon.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »